ON-Demand VideosAdvancing Anticoagulation for Atrial Fibrillation Patients “Lixiana Launch” (18th of December 2020)

https://ecsociety.com/wp-content/uploads/2018/08/ecs_logo_full.png
https://ecsociety.com/wp-content/uploads/2018/08/ema_logo.png
https://ecsociety.com/wp-content/uploads/2018/08/ecs_logo_full.png

Advancing Anticoagulation for Atrial Fibrillation Patients “Lixiana Launch”

Date: 18 December

Time: 19:00-20:30 UAE Time

Chairman: Dr. Wael Almahmeed

Speakers: Dr. Christian T. Ruff /Dr. Hani Sabbour

Supported by
https://ecsociety.com/wp-content/uploads/2020/12/Lixiana.png
https://ecsociety.com/wp-content/uploads/2020/12/saja.jpg
  • Program
  • Preview
  • 19:00-19:05

    Introduction

    Wael Almahmeed, UAE

  • 19:05-19:25

    A new Era in Anticoagulation for AF

    Hani Sabbour, UAE

  • 19:25-20:05

    Insights from the ENGAGE AF-TIMI 48 Trial: The Efficacy and Safety of Edoxaban in High-Risk Patients

    Christian T. Ruff, USA

  • 20:05-20:25

    Panel Discussion

  • 20:25-20:30

    Take Home Message

    Wael Almahmeed, UAE